La bourse est fermée

Gerresheimer AG (GXI.DE)

XETRA - XETRA Prix différé. Devise en EUR
Ajouter à la liste dynamique
85,50-2,35 (-2,68 %)
À la clôture : 5:35PM CEST

Gerresheimer AG

Klaus-Bungert-Strasse 4
Düsseldorf 40468
Germany
49 211 6181 00
http://www.gerresheimer.com

Secteur(s)Healthcare
Secteur d’activitéMedical Instruments & Supplies
Employés à temps plein10 032

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Dietmar SiemssenCEO of Plastics & Devices and Advanced Technologies Division & Chairman of the Management Board1,62MS.O.1963
Dr. Bernd Metzner Ph.D.CFO & Member of the Management Board1,09MS.O.1970
Dr. Lukas BurkhardtMember of the Management Board1,09MS.O.1979
Ms. Katja SchnitzlerMember of Supervisory Board106kS.O.1981
Ms. Carolin NadiloCorp. Director of Investor RelationsS.O.S.O.S.O.
Mr. Jens KürtenGroup Sr. Director of Communication & Marketing and Press Officer of Corp. MediaS.O.S.O.S.O.
Mr. Helmut SchweigerMD & GM of Gerresheimer Horsovsky Tyn PlantS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2020 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en EUR.

Description

Gerresheimer AG, together with its subsidiaries, manufactures and sells specialty glass, plastic products, and drug delivery-devices and solutions primarily worldwide. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables, and components for dialysis machines, and catheters and surgical devices. It also provides containers for the delivery of tablets and powders, liquid dosages, ophthalmic and rhinological applications, parenteral packaging applications, oral prescription medications, and cosmetics. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as ampoules, cartridges, vials, syrup and dropper bottles, tablet jars, and wide-neck jars, as well as injection, infusion, and transfusion bottles; flacons and pots for fragrances, deodorants, and care and decorative cosmetics; and bottles and jars for spirits and food. The Advanced Technologies division develops drug delivery products and platforms, such as micro pumps, which are used to self-administer medication for heart failure or Parkinson's for pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Gerresheimer AG en date du 1 juillet 2021 est 4. Les scores principaux sont Audit : 5; Société : 6; Droits des actionnaires : 1; Compensation : 1.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.